Next Article in Journal
Brain Perception of Different Oils on Appetite Regulation: An Anorectic Gene Expression Pattern in the Hypothalamus Dependent on the Vagus Nerve
Previous Article in Journal
Proteins and Peptides Studied In Silico and In Vivo for the Treatment of Diabetes Mellitus: A Systematic Review
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Prevalence and Impact of Malnutrition Risk on Outcomes in Critically Ill Patients with Traumatic Brain Injury and Stroke: A Retrospective Cohort Study Using Electronic Health Records

by
Alexander E. Shestopalov
1,
Alexandra V. Yakovleva
1,
Mikhail Ya. Yadgarov
1,2,*,
Ivan V. Sergeev
1 and
Artem N. Kuzovlev
1
1
Federal Research and Clinical Center of Intensive Care Medicine and Rehabilitology, Moscow 107031, Russia
2
V. M. Gorbatov Federal Research Center for Food Systems, Russian Academy of Sciences, Moscow 109316, Russia
*
Author to whom correspondence should be addressed.
Nutrients 2024, 16(15), 2396; https://doi.org/10.3390/nu16152396
Submission received: 24 June 2024 / Revised: 22 July 2024 / Accepted: 22 July 2024 / Published: 24 July 2024
(This article belongs to the Section Nutrition and Public Health)

Abstract

:
Background: Malnutrition is a critical concern in ICU settings. It is associated with increased morbidity and mortality, yet its prevalence and impact on clinical outcomes in patients with stroke and traumatic brain injury (TBI) remain underexplored. Objective: To evaluate the prevalence and impact of malnutrition risk on clinical outcomes in ICU patients with TBI, ischemic stroke, and hemorrhagic stroke, and to identify key risk factors associated with malnutrition risk. Methods: This retrospective cohort study utilized electronic health records encompassing ICU admissions from 2017 to 2023. Patients with either stroke or TBI were included, with malnutrition risk assessed using the prognostic nutritional index. Data were extracted and analyzed to determine patient characteristics, clinical and laboratory parameters, and outcomes. Results: This study included 1352 patients (267 TBI, 825 ischemic stroke, and 260 hemorrhagic stroke patients, >30% with pneumonia at admission). Severe malnutrition risk at admission was observed in over 60% of patients. Stroke patients, particularly those with hemorrhagic stroke, exhibited a higher risk of malnutrition compared to TBI patients. Malnutrition risk was associated with significantly higher hospital mortality and increased need for mechanical ventilation. Predictive factors for malnutrition risk included advanced age, higher SOFA scores, lower FOUR and GCS scores, and the presence of pneumonia at admission. Conclusions: Risk of malnutrition is highly prevalent among ICU patients with TBI, ischemic, and hemorrhagic stroke, significantly impacting mortality and other clinical outcomes. Identifying and managing malnutrition early in the ICU setting is crucial for improving patient outcomes. Further prospective, multicenter studies are needed to validate these findings and develop effective interventions.

1. Introduction

“Brain damage” or “brain injury” refers to a severe acute condition affecting the central nervous system, arising from various causes but sharing common pathogenic mechanisms that lead to similar neuropathological syndromes. Stroke and traumatic brain injury are among the most prominent and leading types of brain damage [1].
Among all diagnosed acute cerebrovascular events, ischemic strokes account for 65–85%. Although less frequent, hemorrhagic strokes carry a higher mortality rate [2], ranging from 30 to 50%, with only 10–20% of patients recovering functional activity [3]. Even with the best available treatment, over 30% of stroke survivors are left with severe disabilities, and 20% require specialized medical care three months post-stroke [4]. Of those who survive, 60% become disabled yet manage self-care, 19–35% are entirely dependent on others, and only 15–20% resume their professional lives. Long-term disability is the most prevalent post-stroke complication, posing a significant socioeconomic burden [4,5]. Similarly, traumatic brain injury (TBI) remains a critical medical and public health issue worldwide. TBI is the foremost cause of death and disability among young and middle-aged adults, the most productive and socially active segment of the population. The average mortality rate for severe TBI is a staggering 39%, with 60% of patients experiencing unfavorable outcomes as measured by the Glasgow Outcome Score. TBI holds the grim distinction of being the leading cause of mortality and disability for individuals under 44 years of age [6].
Severe brain injuries result not only in profound physical and mental impairments but also in significant disruptions to metabolism and nutritional status. Malnutrition in patients with brain injuries is a critical concern due to its widespread prevalence, including among young and middle-aged individuals. This condition often leads to serious complications such as infectious and trophic disorders. Patients frequently develop issues like pneumonia, bedsores, and polyneuropathy, which are associated with prolonged immobilization and impaired nutritional status [7,8,9]. Additionally, the high rates of mortality and disability, along with the severe and prolonged loss of work capability, underscore the gravity of these consequences [10,11,12].
Malnutrition and metabolic disturbances are among the foremost complications in stroke patients, significantly impacting the prognosis and treatment outcomes [13,14]. Expert assessments indicate that approximately 20% of patients admitted with acute stroke suffer from malnutrition, with some studies reporting figures as high as 62%. Three weeks post-admission, 56.3% of patients with severe stroke exhibit signs of malnutrition. By the time of discharge, 61% of stroke patients are found to be at risk of malnutrition [15,16,17].
The prevalence and impact of malnutrition on outcomes in critically ill patients with TBI and stroke is a multifaceted issue. Despite extensive data on the nutritional status, protein, and energy deficiencies in these patients, there remains a lack of clarity regarding the true incidence of malnutrition in these populations.
Although the ESPEN guidelines on clinical nutrition in neurology [18] indicate a strong consensus on the importance of screening for malnutrition at admission and provide comprehensive methods for early diagnosis, prevention, and correction of nutritional deficiencies and metabolic disorders, there remains variability in their implementation across clinical settings. This inconsistency may hinder the optimization of treatment outcomes and the efficacy of rehabilitation efforts.
The aim of this study was to evaluate the prevalence, outcomes, and predictors of malnutrition risk among ICU patients with traumatic brain injury, ischemic stroke, and hemorrhagic stroke.

2. Materials and Methods

2.1. Data Sources

This retrospective, single-center cohort study utilized electronic health records (EHRs) from the Federal Research and Clinical Center of Intensive Care Medicine and Rehabilitology (Russian Intensive Care Dataset, RICD [19,20]). The data encompassed all patients admitted to the intensive care units (ICUs) between December 2017 and July 2023. The study was approved by the local ethics committee (No. 4/23/2, 20 December 2023).

2.2. Selection Criteria

This study included patients diagnosed with either stroke or TBI who were admitted to the ICU. The exclusion criteria were as follows: (1) nonprimary ICU admission in our medical center, (2) length of ICU stay <24 h, (3) anoxic brain injury, (4) brain tumors. The patients with missing information on malnutrition risk status at admission and ICD-10 diagnoses were also excluded. The risk of malnutrition was assessed at ICU admission using prognostic nutritional index (PNI) score, and PNI was calculated as [10 × serum albumin (g/dL)] + [0.005 × absolute lymphocyte count (per mm3)] [21]. Patients were stratified into three nutritional status groups based on PNI scores: normal nutrition (PNI > 38), moderate risk of malnutrition (PNI = 35–38), and severe risk of malnutrition (PNI < 35) [22]. We categorized moderate and severe in the same group “at risk of malnutrition”.

2.3. Data Extraction

The data from EHRs were extracted using SQLite version 3.45.2 (https://www.sqlite.org/, accessed on 14 June 2024). The parameters analyzed included the following: (1) general patient information-sex, age, body mass index (BMI), and whether the patient was transferred from another hospital; (2) clinical data-acute physiology and chronic health evaluation II (APACHE II), sequential organ failure assessment (SOFA), Full Outline of UnResponsiveness (FOUR), Glasgow coma scale (GCS), and Coma Recovery Scale-Revised (CRS-R) scores at admission, pneumonia at admission, and comorbidity; (3) laboratory data at admission for white blood cell (WBC) count, neutrophil and lymphocyte counts, neutrophil-to-lymphocyte ratio (NLR), platelet count, International Normalized Ratio (INR), albumin, total protein, and cholesterol; and (4) outcomes of hospital mortality, length of hospital stay, need for mechanical ventilation (MV), use of vasoactive drugs, and discharge location. For patients with multiple laboratory measurements on the same day, the earliest values were analyzed.

2.4. Outcomes

The primary endpoint was the prevalence of malnutrition risk among ICU patients with TBI, ischemic, and hemorrhagic strokes. The secondary endpoints included all-cause mortality, MV and vasoactive drugs usage, and the duration of hospitalization. Additional analyses identified risk factors associated with the malnutrition risk.

2.5. Statistical Analysis

Data distribution was assessed using the Shapiro–Wilk test. Continuous variables were reported as medians (Me) and interquartile ranges (IQRs), while categorical variables were expressed as frequencies and percentages. The chi-square test and Fisher’s exact test (with Fisher–Freeman–Halton exact extension where applicable) were used for comparing categorical variables. The Kruskal–Wallis test and Mann–Whitney U-test (Wilcoxon rank-sum test) were applied for continuous variables.
Survival analysis was performed using Kaplan–Meier survival curves, with cumulative risk functions estimated via the Nelson–Aalen estimator. Differences in survival between groups were evaluated using the log-rank test. Multivariable Cox regression analysis was conducted to identify independent predictors of mortality, with backward feature selection (Wald) revealing adjusted hazard ratios (HRs) and 95% confidence intervals (CIs).
The optimal cutoff point for the PNI score was determined using receiver operating characteristic (ROC) analysis and the Youden index to maximize sensitivity and specificity. Missing data were not imputed. Statistical significance was set at p < 0.05 (two-sided) if a Bonferroni multiple-significance-test correction was not applied. All the statistical calculations were performed using IBM SPSS Statistics v. 29.0 and Stata v. 18.0.

3. Results

3.1. Patient Characteristics

A flowchart depicting the patient selection process for the study is presented in Figure 1. Initially, 1754 patients with either stroke or TBI were admitted to the ICUs. Following the application of exclusion criteria, 1352 patients were included in the final analysis. This cohort comprised 267 patients with TBI (20%), 825 patients with ischemic stroke (61%), and 260 patients with hemorrhagic stroke (19%).
Baseline characteristics, disease characteristics, and outcomes for all patients are summarized in Table 1. The mean age was 42 years (IQR 29–56) in the TBI group, 69 years (IQR 60–78) in the ischemic stroke group, and 59 years (IQR 48–68) in the hemorrhagic stroke group (p < 0.001). The TBI group had a predominantly male population, whereas females were more prevalent in both stroke groups. Over 90% of stroke patients and 64% of TBI patients were transferred from other hospitals. Stroke patients exhibited a higher prevalence of comorbidities.
Severe risk of malnutrition at admission was observed in over 60% of the patients. Hospital mortality rates were 6.7% for the TBI group, 8.1% for the hemorrhagic stroke group, and 14.8% for the ischemic stroke group (p < 0.001). Mechanical ventilation was required for more than 40% of the patients, and vasoactive drugs were administered to 13–18% of patients, as detailed in Table 1. Patients with TBI had a longer median hospital stay (39 days) compared to those with hemorrhagic stroke (36 days) and ischemic stroke (31 days), p < 0.001. Approximately half of the patients were discharged to other ICUs, while the remainder were discharged for further treatment or rehabilitation.
A Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) checklist for this study is provided in Supplementary Material Table S1.

3.2. Prevalence of Malnutrition Risk

A significant proportion of patients exhibited severe risk of malnutrition upon ICU admission, with over 60% of those with TBI and ischemic stroke, and over 70% of patients with hemorrhagic stroke (Table 1). Specifically, the PNI scores were lowest among hemorrhagic stroke patients, with a median of 31.3 (IQR 27.9–35.3), followed by ischemic stroke patients with a median of 32.2 (IQR 27.3–36.7), and TBI patients with a median of 33.4 (IQR 28.2–37.7) (p = 0.025).
Stroke patients exhibited significantly elevated NLR values (p < 0.001) and reduced levels of platelets (p < 0.001), INR (p = 0.026), albumin (p = 0.025), total protein (p < 0.001), and cholesterol (p = 0.009) (Table 1).

3.3. Outcomes

The analysis of cumulative hospital mortality risk revealed a significantly increased risk for patients with ischemic stroke and moderate/severe risk of malnutrition compared to those with normal nutritional status (p = 0.011, Figure 2).
Patients at risk of malnutrition exhibited significantly higher hospital mortality rates in the TBI (9.9% vs. 3.2%, p = 0.048) and ischemic stroke (22.8% vs. 9.0%, p < 0.001) groups, whereas no significant difference was observed in the hemorrhagic stroke group (p = 0.181) (Table 2 and Table 3). PNI score was a significant predictor of mortality in univariate analysis (HR 0.918, p < 0.001), but only age and SOFA remained significant predictors in multivariable analysis (Table 2).
Optimal cutoff points for the PNI score to predict mortality were established for each patient group: <33.8 for TBI, <31.6 for hemorrhagic stroke, and <30.8 for ischemic stroke (Table 3). Based on these thresholds, malnutrition risk was identified in 142 out of 267 (53%) TBI patients, 347 out of 825 (42%) ischemic stroke patients, and 136 out of 260 (52%) hemorrhagic stroke patients.
Additionally, malnutrition risk was associated with an increased need for MV across all patient groups (p < 0.001) and a higher requirement for vasoactive drugs, except in the hemorrhagic stroke group. Notably, ischemic stroke patients at risk of malnutrition also had shorter hospital stays (Table 3).

3.4. Predictors of Malnutrition Risk

Patients with stroke, particularly those with hemorrhagic stroke, exhibited a higher risk of malnutrition compared to patients with TBI (Table 1).
In all groups, patients at risk of malnutrition were generally older (p < 0.001), had higher SOFA scores, lower FOUR, GCS scores (p < 0.001), and CRS-R scores (p = 0.037), and were more likely to have pneumonia at admission (p < 0.01) (Table 3). Female sex emerged as a statistically significant risk factor among patients with hemorrhagic stroke (p = 0.004). Coronary artery disease was identified as a risk factor for malnutrition across all patient groups (p < 0.01), while arterial hypertension was specifically significant in the TBI group (p < 0.001).
Patients at risk of malnutrition demonstrated elevated WBC counts, NLR, and INR, along with reduced levels of albumin, total protein, and cholesterol (all p < 0.03). Additionally, platelet counts were significantly lower in patients with ischemic stroke (p < 0.001). Moreover, patients with elevated malnutrition risk and ischemic stroke also presented with a higher prevalence of anemia (p = 0.04) (Table 3).
Table 3. Outcomes and predictors of malnutrition risk.
Table 3. Outcomes and predictors of malnutrition risk.
ParametersTraumatic Brain Injury, n = 267Ischemic Stroke, n = 825Hemorrhagic Stroke, n = 260
Normal Nutrition (Not at Risk of Malnutrition)
n = 125
PNI ≥ 33.8
At Risk of Malnutrition
n = 142
PNI < 33.8
p ValueNormal Nutrition (Not at Risk of Malnutrition)
n = 478
PNI ≥ 30.8
At Risk of Malnutrition
n = 347
PNI < 30.8
p ValueNormal Nutrition (Not at Risk of Malnutrition)
n = 124
PNI ≥ 31.6
At Risk of Malnutrition
n = 136
PNI < 31.6
p Value
Sexmale85, 68%108, 76%0.142 1274, 57%175, 50%0.05 182, 66%66, 49%0.004 1
female40, 32%34, 24%204, 43%172, 50%42, 34%70, 51%
Age, years34 (IQR 24–48)48 (IQR 37–60)<0.001 266 (IQR 58–75)72 (IQR 63–81)<0.001 252.5 (IQR 41–63.5)63 (IQR 56–69.5)<0.001 2
BMI, kg/m2* n = 113, 21.6 (IQR 19.0–24.6)n = 127, 22.1 (IQR 18.9–25.4)0.4 2n = 425, 26.1 (IQR 23.0–30.5)n = 319, 26.1 (IQR 22.8–30.8)0.8 2n = 118, 25.6 (IQR 21.8–29.4)n = 122, 25.5 (IQR 22.6–30.03)0.86
SOFA at admission, scoren = 78, 2 (IQR 1–3)n = 104, 3 (IQR 2–5)<0.001 2n = 330, 2 (IQR 1–3)n = 269, 4 (IQR 3–6)<0.001 2n = 89, 2 (IQR 0–3)n = 92, 3 (IQR 2–4)<0.001 2
FOUR at admission, scoren = 79, 15 (IQR 14–16)n = 110, 13 (IQR 10–15)<0.001 2n = 352, 16 (IQR 15–16)n = 269, 13 (IQR 9–16)<0.001 2n = 97, 16 (IQR 14–16)n = 94, 13 (IQR 11–16)<0.001 2
GCS at admission, scoren = 81, 13 (IQR 10–15)n = 111, 10 (IQR 8–14)<0.001 2n = 358, 15 (IQR 12–15)n = 277, 11 (IQR 8–14)<0.001 2n = 98, 14 (IQR 12–15)n = 97, 11 (IQR 9–14)<0.001 2
CRS-R at admission, score n = 59, 14 (IQR 5–22)n = 69, 10 (IQR 5–18)0.037 2n = 228, 22 (IQR 17–23)n = 165, 13 (IQR 5–20)<0.001 2n = 54, 21 (IQR 17–22)n = 67, 12 (IQR 5–20)<0.001 2
Pneumonia at admission31, 25%57, 40%0.008 1108, 23%184, 53%<0.001 124, 20%65, 48%<0.001 1
Coronary artery disease2, 1.6%15, 10.6%0.002 388, 19%125, 36%<0.001 113, 11%31, 23%0.008 1
Arterial hypertension23, 18%59, 42%<0.001 1376, 79%257, 74%0.123 192, 74%105, 77%0.6 1
Type 2 diabetes0, 0%3, 2.1%0.3 326, 5.4%26, 7.5%0.2 36, 4.8%5, 3.7%0.7 3
Anemia5, 4.0%12, 8.5%0.2 37, 1.5%13, 3.7%0.04 33, 2.4%10, 7.4%0.089 3
WBC, 109/L7.4 (IQR 6.2–9.7)9.1 (IQR 7.1–11.5)0.002 28.3 (IQR 6.6–10.6)9.83 (IQR 7.3–12.6)<0.001 28.5 (IQR 6.45–11.575)8.7 (IQR 6.6–11.62)0.66
NLR3.2 (IQR 2.2–5.3)5.0 (IQR 3.2–8.2)<0.001 23.9 (IQR 2.6–6.6)7.1 (IQR 4.2–12.6)<0.001 23.5 (IQR 2.5–7.4)6 (IQR 3.9–10.0)<0.001 2
Platelets, 109/L344 (IQR 260–442)325 (IQR 244–416)0.3 2264 (IQR 212–332)242 (IQR 185–314)<0.001 2311 (IQR 231–379.5)294 (IQR 226–376.5)0.5 2
INRn = 123, 1.14 (IQR 1.06–1.27)n = 139, 1.21 (IQR 1.13–1.36)0.004 2n = 474, 1.11 (IQR 1.02–1.24)n = 342, 1.225 (IQR 1.1–1.35)<0.001 2n = 123, 1.12 (IQR 1.06–1.22)n = 135, 1.2 (IQR 1.08–1.35)0.001 2
Albumin, g/L37.9 (IQR 35.9–40.7)28.35 (IQR 25.1–31.9)<0.001 236 (IQR 33.4–38.8)26.5 (IQR 23.8–28.7)<0.001 235.85 (IQR 33.55–38.15)28 (IQR 25.55–30)<0.001 2
Total protein, g/Ln = 124, 68.8 (IQR 66.4–72.2)n = 140, 59.2 (IQR 54.5–64.9)<0.001 2n = 460, 66.2 (IQR 62.2–70.2)n = 335, 55.4 (IQR 50.7–59.4)<0.001 2n = 119, 65.7 (IQR 62.6–70.1)n = 135, 57 (IQR 53.2–61.6)<0.001 2
Cholesterol, mmol/Ln = 12, 5.71 (IQR 4.52–6.37)n = 4, 3.79 (IQR 3.13–4.52)0.02 2n = 39, 4.42 (IQR 3.62–5.43)n = 25, 3.37 (IQR 2.92–3.82)0.002 2n = 10, 5.46 (IQR 4.43–6.02)n = 13, 3.61 (IQR 2.88–4.38)0.004 2
Outcomes
Hospital mortality4, 3.2%14, 9.9%0.048 343, 9.0%79, 22.8%<0.001 37, 5.6%14, 10.3%0.181 3
Hospital length of stay, days38 (IQR 27–62)39.5 (IQR 22–64)0.9 234 (IQR 23–47)25 (IQR 22–47)<0.001 236.5 (IQR 26.5–52)35 (IQR 23–60)0.6 2
Need for MV42, 34%84, 59%<0.001 1123, 26%237, 68%<0.001 147, 38%90, 66%<0.001 1
Use of vasoactive drugs12, 9.6%32, 23%0.005 252, 11%92, 27%<0.001 111, 8.9%23, 16.9%0.066 2
1—Chi-square test; 2—Mann–Whitney U-test; 3—Fisher’s exact test (Fisher–Freeman–Halton exact test). Qualitative data presented in Me (IQR) format. * Number of patients (n) is given when missing data are present. Optimal cut-off values from ROC-analysis. Abbreviations: BMI, body mass index; SOFA, Sequential Organ Failure Assessment; FOUR, Full Outline of UnResponsiveness; GCS, Glasgow coma scale; CRS-R, Coma Recovery Scale-Revised; MV, mechanical ventilation; PNI, prognostic nutritional index; WBC, white blood cell count; NLR, neutrophil-to-lymphocyte ratio; INR, International Normalized Ratio; IQR, interquartile range.

4. Discussion

4.1. Key Findings

This retrospective, single-center cohort study investigated the prevalence and impact of malnutrition risk among ICU patients diagnosed with either stroke (ischemic or hemorrhagic) or TBI over a period of nearly six years. The study revealed that elevated malnutrition risk was highly prevalent across all patient groups, with over 60% of patients with TBI and ischemic stroke, and over 70% of patients with hemorrhagic stroke, showing severe risk of malnutrition upon admission. Stroke patients, particularly those with hemorrhagic stroke, had a higher risk of malnutrition compared to TBI patients.
This study identified several adverse outcomes associated with malnutrition risk. Patients at risk of malnutrition exhibited higher hospital mortality rates, increased need for mechanical ventilation, and more frequent use of vasoactive drugs. Key risk factors for malnutrition included advanced age, higher SOFA scores, lower FOUR, GCS, and CRS-R scores, and the presence of pneumonia at admission. Additionally, female sex was a significant risk factor in hemorrhagic stroke patients, while coronary artery disease and arterial hypertension were notable risk factors across different patient groups.

4.2. Relationship with Previous Studies

The results of our study align with existing research on malnutrition in stroke patients. Previous reviews report malnutrition rates in stroke patients ranging from 6.1% to 62% [23,24]. This variability can be attributed to differences in stroke type (ischemic/hemorrhagic), comorbidities, and complications. However, the primary reason for this variability is the use of different methods and scales to assess nutritional status [17,25]. Studies utilizing the PNI have reported moderate to severe malnutrition risk rates ranging from 2% to 31% in stroke patients [24], which contrasts with our center’s higher rates of approximately 75–85%. This discrepancy likely arises because our patients were predominantly transferred to us from other centers, where they had also been in ICUs. The prolonged critical condition, combined with the accumulating negative effects of intensive therapy methods, most likely led to a systemic inflammatory response followed by the development of hypercatabolism and immunosuppression. Consequently, this resulted in low plasma albumin levels and a reduced absolute lymphocyte count, which, according to current understanding, constitutes malnutrition. Moreover, the use of common scales such as the Malnutrition Universal Screening Tool (MUST), Nutritional Risk Screening 2002 (NRS-2002), and Mini Nutritional Assessment Short Form (MNA-SF) is not feasible in our setting due to impaired consciousness and limitations in our study cohort [24,26].
Our study also confirmed that risk factors such as advanced age, reduced level of consciousness, female sex, arterial hypertension, and pneumonia are significant predictors of malnutrition risk in stroke patients [27,28]. Risk factors for malnutrition in TBI patients, such as pulmonary infection and GCS score, identified in the study by Cai et al., were also significant in our research [29].
One of the largest studies, the FOOD Trial Collaboration [30], investigated the impact of nutritional status on stroke patient outcomes over six years across six countries, involving 3012 patients in 112 hospitals. The study found that malnutrition significantly increased the mortality rate and the risk of complications such as pneumonia and gastrointestinal bleeding. Specifically, the mortality rate was 37% in patients at risk of malnutrition compared to 20% in those with normal nutritional status [30]. Additionally, patients with normal nutrition showed higher levels of independence in daily activities, as measured by the Rankin scale, with 30.0%, compared to 17.1% in patients at risk of malnutrition. Thus, low nutritional status in stroke patients is a predictor of poor outcomes and increased mortality. Malnutrition negatively impacts recovery, reducing motor and cognitive function recovery, social and daily adaptation, and overall quality of life [13,30,31,32].
Our analysis indicates that moderate or severe risk of malnutrition is common among TBI patients of all ages and genders. There is a clear association between the severity of malnutrition and the risk of infectious and inflammatory complications in TBI patients. Those with severe TBI are at risk for prolonged nitrogen loss and exhaustion, leading to increased susceptibility to infections, poor wound healing, and longer durations on mechanical ventilation [11,12]. Malnutrition is an independent risk factor for nosocomial infections and adverse clinical outcomes, including prolonged hospitalization and increased mortality [11,12,33]. Similarly, our study demonstrated that patients at risk of malnutrition had a higher mortality rate, longer hospital stays, and a greater frequency of mechanical ventilation use.
Our findings support previous research indicating that malnutrition adversely affects clinical outcomes and underscores the utility of PNI as a prognostic criterion [34]. For instance, S. Nergiz and U. Ozturk demonstrated a strong association between low PNI levels and secondary infections in acute stroke patients, with 21% developing secondary infections and 69% of patients experiencing malnutrition [35]. This association contributes to prolonged hospital stays and increased mortality. Our previous data also show higher malnutrition rates and hospital-acquired pneumonia incidence in early neurorehabilitation patients, attributable to longer ICU stays and the chronic nature of their conditions [36].

4.3. Significance of the Study Findings

The significance of our findings is supported by several key points.
Firstly, it was shown that risk of malnutrition in patients with brain injury is a risk factor for mortality, prolonged hospitalization, and the need for mechanical ventilation. It is crucial to understand that this condition may be rooted in a persistent systemic inflammatory response, leading to dysfunction in various organs and systems. This conclusion is further supported by multivariate analysis, which identifies the severity of multiple organ failure as an independent factor for mortality, and pneumonia at admission as a risk factor for malnutrition.
Secondly, our study revealed that malnutrition is not a uniform condition. Kaplan–Meier curves clearly demonstrate differences in mortality risk between patients with moderate and severe risk of malnutrition, with the PNI score being a significant predictor of mortality. This finding suggests the need for stratifying patients based on the severity of malnutrition to guide management strategies and assess the risk of adverse outcomes. Moreover, the high prevalence of severe risk of malnutrition, particularly in hemorrhagic stroke patients, underscores the need for comprehensive nutritional status assessment as a standard component of ICU care.
Thirdly, our study demonstrated that malnutrition risk is associated with profound metabolic disturbances, as evidenced by elevated NLR, increased INR, and decreased levels of albumin, total protein, and cholesterol at admission. Patients with malnutrition risk exhibited disruptions in coagulation hemostasis, immune status, and the body’s synthetic functions. This aspect underscores the high clinical significance of malnutrition, reflecting the extent of homeostatic imbalances. The study advocates treating these patients as polymorbid, emphasizing that nutritional therapy should be integrated into their broader management plans [37].

4.4. Strengths and Limitations

This study’s major strength lies in being conducted using a large and comprehensive EHR dataset from a single-center ICU over a six-year period.
However, several limitations should be acknowledged. Being a single-center study, the findings may not be fully generalizable to other settings with different patient demographics or healthcare practices. The retrospective design inherently carries the risk of data missingness and potential biases in data recording. The exclusion of patients with incomplete malnutrition status data or ICD-10 diagnoses might have introduced selection bias. Additionally, the observational nature of the study precludes establishing reliable causality.
Our study assessed only the risk of malnutrition using the PNI score, which incorporates serum albumin and lymphocyte count [38]. It is important to note that the PNI score may also reflect critical illness-related inflammation, which may confound its specificity for nutritional status [39]. Due to the retrospective nature of our study, we lacked the data necessary to perform physical examinations and assess muscle mass, preventing the use of the Global Leadership Initiative on Malnutrition (GLIM) criteria and other tools for malnutrition diagnosis [40].
Future multicenter, prospective studies are warranted to validate and expand upon these findings, incorporating comprehensive nutritional assessments including muscle mass evaluation.

5. Conclusions

This study demonstrates a high prevalence of severe malnutrition risk among ICU patients with traumatic brain injury, ischemic stroke, and hemorrhagic stroke, associated with worse clinical outcomes such as higher mortality and increased need for mechanical ventilation. These findings emphasize the need for early nutritional assessment and intervention to improve outcomes in ICU patients. Future multicenter studies are essential to validate and expand upon these results.

Supplementary Materials

The following supporting information can be downloaded at: https://www.mdpi.com/article/10.3390/nu16152396/s1, Table S1: STROBE checklist.

Author Contributions

Conceptualization, A.E.S., A.V.Y. and M.Y.Y.; methodology, A.V.Y. and M.Y.Y.; validation, A.V.Y. and M.Y.Y.; formal analysis, M.Y.Y.; writing—original draft preparation, A.E.S., A.V.Y., M.Y.Y., I.V.S. and A.N.K.; writing—review and editing, A.E.S., A.V.Y., M.Y.Y., I.V.S. and A.N.K. All authors have read and agreed to the published version of the manuscript.

Funding

This work was supported by the Ministry of Science and Education of the Russian Federation (Grant Agreement 075-15-2024-483).

Institutional Review Board Statement

This study was approved by the local ethics committee (No. 4/23/2, 20 December 2023).

Informed Consent Statement

Not applicable.

Data Availability Statement

Restrictions apply to the availability of these data. Data were obtained from RICD and are available at https://fnkcrr-database.ru (accessed on 20 June 2024) with the permission of Federal Research and Clinical Center of Intensive Care Medicine and Rehabilitology.

Conflicts of Interest

The authors declare no conflicts of interest.

References

  1. Goldman, L.; Siddiqui, E.M.; Khan, A.; Jahan, S.; Rehman, M.U.; Mehan, S.; Sharma, R.; Budkin, S.; Kumar, S.N.; Sahu, A.; et al. Understanding Acquired Brain Injury: A Review. Biomedicines 2022, 10, 2167. [Google Scholar] [CrossRef] [PubMed]
  2. Woodruff, T.M.; Thundyil, J.; Tang, S.C.; Sobey, C.G.; Taylor, S.M.; Arumugam, T.V. Pathophysiology, Treatment, and Animal and Cellular Models of Human Ischemic Stroke. Mol. Neurodegener. 2011, 6, 11. [Google Scholar] [CrossRef] [PubMed]
  3. Takahata, H.; Tsutsumi, K.; Baba, H.; Nagata, I.; Yonekura, M. Early Intervention to Promote Oral Feeding in Patients with Intracerebral Hemorrhage: A Retrospective Cohort Study. BMC Neurol. 2011, 11, 6. [Google Scholar] [CrossRef] [PubMed]
  4. Scherbakov, N.; Doehner, W. Sarcopenia in Stroke-Facts and Numbers on Muscle Loss Accounting for Disability after Stroke. J. Cachexia Sarcopenia Muscle 2011, 2, 5–8. [Google Scholar] [CrossRef] [PubMed]
  5. Aquilani, R.; Sessarego, P.; Iadarola, P.; Barbieri, A.; Boschi, F. Nutrition for Brain Recovery after Ischemic Stroke: An Added Value to Rehabilitation. Nutr. Clin. Pract. 2011, 26, 339–345. [Google Scholar] [CrossRef] [PubMed]
  6. Brazinova, A.; Rehorcikova, V.; Taylor, M.S.; Buckova, V.; Majdan, M.; Psota, M.; Peeters, W.; Feigin, V.; Theadom, A.; Holkovic, L.; et al. Epidemiology of Traumatic Brain Injury in Europe: A Living Systematic Review. J. Neurotrauma 2021, 38, 1411–1440. [Google Scholar] [CrossRef] [PubMed]
  7. Saghaleini, S.H.; Dehghan, K.; Shadvar, K.; Sanaie, S.; Mahmoodpoor, A.; Ostadi, Z. Pressure Ulcer and Nutrition. Indian J. Crit. Care Med. 2018, 22, 283–289. [Google Scholar] [CrossRef] [PubMed]
  8. Chen, B.; Liu, W.; Chen, Y.; She, Q.; Li, M.; Zhao, H.Y.; Zhao, W.; Peng, Z.; Wu, J. Effect of Poor Nutritional Status and Comorbidities on the Occurrence and Outcome of Pneumonia in Elderly Adults. Front. Med. 2021, 8, 719530. [Google Scholar] [CrossRef] [PubMed]
  9. Hammond, N.; Wang, Y.; Dimachkie, M.M.; Barohn, R.J. Nutritional Neuropathies. Neurol. Clin. 2013, 31, 477–489. [Google Scholar] [CrossRef]
  10. Ford, L.M.; Ouma, J.R. A Descriptive Study of Malnutrition in Traumatic Brain Injury Patients. Panam. J. Trauma Crit. Care Emerg. Surg. 2022, 10, 107–112. [Google Scholar] [CrossRef]
  11. Poblete, R.A.; Yaceczko, S.; Aliakbar, R.; Saini, P.; Hazany, S.; Breit, H.; Louie, S.G.; Lyden, P.D.; Partikian, A. Optimization of Nutrition after Brain Injury: Mechanistic and Therapeutic Considerations. Biomedicines 2023, 11, 2551. [Google Scholar] [CrossRef] [PubMed]
  12. Jeong, H.; Kim, J.H.; Choo, Y.H.; Kim, M.; Lee, S.; Ha, E.J.; Oh, J. Nutrition Therapy for Patients with Traumatic Brain Injury: A Narrative Review. Korean J. Neurotrauma 2023, 19, 177–184. [Google Scholar] [CrossRef] [PubMed]
  13. Ko, S.-H.; Shin, Y.-I. Nutritional Supplementation in Stroke Rehabilitation: A Narrative Review. Brain Neurorehabilit. 2022, 15, e3. [Google Scholar] [CrossRef] [PubMed]
  14. Yoo, S.H.; Kim, J.S.; Kwon, S.U.; Yun, S.C.; Koh, J.Y.; Kang, D.W. Undernutrition as a Predictor of Poor Clinical Outcomes in Acute Ischemic Stroke Patients. Arch. Neurol. 2008, 65, 39–43. [Google Scholar] [CrossRef] [PubMed]
  15. Mansare, M.L.; Kouda, D.A.; Diallo, I.M.; Bakhoum, M.; Mourabit, S.; Toure, K.; Ndiaye, M.; Diop, A.G.; Ndiaye, M.M. What Is the Nutritional Status of Your Patients Suffering from Strokes. Rev. Neurol. 2020, 176, 366–369. [Google Scholar] [CrossRef]
  16. Bouziana, S.D.; Tziomalos, K. Malnutrition in Patients with Acute Stroke. J. Nutr. Metab. 2011, 2011, 167898. [Google Scholar] [CrossRef] [PubMed]
  17. Corrigan, M.L.; Escuro, A.A.; Celestin, J.; Kirby, D.F. Nutrition in the Stroke Patient. Nutr. Clin. Pract. 2011, 26, 242–252. [Google Scholar] [CrossRef] [PubMed]
  18. Burgos, R.; Bretón, I.; Cereda, E.; Desport, J.C.; Dziewas, R.; Genton, L.; Gomes, F.; Jésus, P.; Leischker, A.; Muscaritoli, M.; et al. ESPEN Guideline Clinical Nutrition in Neurology. Clin. Nutr. 2018, 37, 354–396. [Google Scholar] [CrossRef]
  19. Grechko, A.V.; Yadgarov, M.Y.; Yakovlev, A.A.; Berikashvili, L.B.; Kuzovlev, A.N.; Polyakov, P.A.; Kuznetsov, I.V.; Likhvantsev, V.V. Russian Intensive Care Dataset–RICD. Obs. Reanimatol. 2024, 20, 22–31. [Google Scholar] [CrossRef]
  20. Russian Intensive Care Dataset–RICD. Available online: https://fnkcrr-database.ru/ (accessed on 23 June 2024).
  21. Shirakabe, A.; Hata, N.; Kobayashi, N.; Okazaki, H.; Matsushita, M.; Shibata, Y.; Nishigoori, S.; Uchiyama, S.; Asai, K.; Shimizu, W. The Prognostic Impact of Malnutrition in Patients with Severely Decompensated Acute Heart Failure, as Assessed Using the Prognostic Nutritional Index (PNI) and Controlling Nutritional Status (CONUT) Score. Heart Vessels 2018, 33, 134–144. [Google Scholar] [CrossRef]
  22. Zhuang, C.; Chen, Y.; Ruan, J.; Yu, H.; Zhu, P.; Zhu, Y.Z. Correlation between the Prognostic Nutritional Index and Outcomes in Older Patients Aged ≥ 60 Years with Chronic Heart Failure. Int. J. Clin. Pharm. 2023, 45, 163–173. [Google Scholar] [CrossRef] [PubMed]
  23. Kim, Y.; Lee, M.; Mo, H.J.; Kim, C.; Sohn, J.H.; Yu, K.H.; Lee, S.H. The Association between Malnutrition Status and Hemorrhagic Transformation in Patients with Acute Ischemic Stroke Receiving Intravenous Thrombolysis. BMC Neurol. 2023, 23, 106. [Google Scholar] [CrossRef] [PubMed]
  24. Di Vincenzo, O.; Luisi, M.L.E.; Alicante, P.; Ballarin, G.; Biffi, B.; Gheri, C.F.; Scalfi, L. The Assessment of the Risk of Malnutrition (Undernutrition) in Stroke Patients. Nutrients 2023, 15, 683. [Google Scholar] [CrossRef] [PubMed]
  25. Foley, N.C.; Salter, K.L.; Robertson, J.; Teasell, R.W.; Woodbury, M.G. Which Reported Estimate of the Prevalence of Malnutrition after Stroke Is Valid? Stroke 2009, 40, e66–e74. [Google Scholar] [CrossRef] [PubMed]
  26. Singer, P.; Blaser, A.R.; Berger, M.M.; Calder, P.C.; Casaer, M.; Hiesmayr, M.; Mayer, K.; Montejo-Gonzalez, J.C.; Pichard, C.; Preiser, J.C.; et al. ESPEN Practical and Partially Revised Guideline: Clinical Nutrition in the Intensive Care Unit. Clin. Nutr. 2023, 42, 1671–1689. [Google Scholar] [CrossRef] [PubMed]
  27. Sabbouh, T.; Torbey, M.T. Malnutrition in Stroke Patients: Risk Factors, Assessment, and Management. Neurocrit. Care 2018, 29, 374–384. [Google Scholar] [CrossRef] [PubMed]
  28. Yoon, J.; Baek, S.; Jang, Y.; Lee, C.H.; Lee, E.S.; Byun, H.; Oh, M.K. Malnutrition and Associated Factors in Acute and Subacute Stroke Patients with Dysphagia. Nutrients 2023, 15, 3739. [Google Scholar] [CrossRef] [PubMed]
  29. Cai, A.; Li, Y.; Xi, X.; Wang, Q.; Yang, J.; Wang, L.; Li, H.; Luo, X.; Zeng, X. Analysis of Risk Factors and Development of Predictive Model for Malnutrition in Patients with Traumatic Brain Injury. Nutr. Neurosci. 2024. [Google Scholar] [CrossRef] [PubMed]
  30. Dennis, M. Poor Nutritional Status on Admission Predicts Poor Outcomes after Stroke Observational Data from the Food Trial. Stroke 2003, 34, 1450–1455. [Google Scholar] [CrossRef]
  31. Bendavid, I.; Zusman, O.; Kagan, I.; Theilla, M.; Cohen, J.; Singer, P. Early Administration of Protein in Critically Ill Patients: A Retrospective Cohort Study. Nutrients 2019, 11, 106. [Google Scholar] [CrossRef]
  32. Compher, C.; Chittams, J.; Sammarco, T.; Nicolo, M.; Heyland, D.K. Greater Protein and Energy Intake May Be Associated with Improved Mortality in Higher Risk Critically Ill Patients: A Multicenter, Multinational Observational Study. Crit. Care Med. 2017, 45, 156–163. [Google Scholar] [CrossRef] [PubMed]
  33. Kim, H.K.; Leigh, J.H.; Lee, Y.S.; Choi, Y.; Kim, Y.; Kim, J.E.; Cho, W.S.; Seo, H.G.; Oh, B.M. Decreasing Incidence and Mortality in Traumatic Brain Injury in Korea, 2008–2017: A Population-Based Longitudinal Study. Int. J. Environ. Res. Public Health 2020, 17, 6197. [Google Scholar] [CrossRef] [PubMed]
  34. Wang, X.; Kang, Z.; Wang, Y.; Zheng, Y.; Wei, Y. Application of Prognostic Nutritional Index in the Predicting of Prognosis in Young Adults with Acute Ischemic Stroke. World Neurosurg. 2023, 178, e292–e299. [Google Scholar] [CrossRef] [PubMed]
  35. Nergiz, S.; Ozturk, U. The Effect of Prognostic Nutritional Index on Infection in Acute Ischemic Stroke Patients. Medicina 2023, 59, 679. [Google Scholar] [CrossRef] [PubMed]
  36. Grechko, A.V.; Gurkova, M.M.; Zhdanova, M.A.; Zurabov, A.Y.; Zurabov, F.M.; Kuzovlev, A.N.; Petrova, M.V.; Polyakov, P.A.; Cheboksarov, D.V.; Chernevskaya, E.A.; et al. Prevention of Nosocomial Pneumonia Recurrence Using a Bacteriophage Cocktail in Intensive Care Unit. Russ. J. Anesthesiol. Reanimatol. 2024, 39–48. [Google Scholar] [CrossRef]
  37. Wunderle, C.; Gomes, F.; Schuetz, P.; Stumpf, F.; Austin, P.; Ballesteros-Pomar, M.D.; Cederholm, T.; Fletcher, J.; Laviano, A.; Norman, K.; et al. ESPEN Guideline on Nutritional Support for Polymorbid Medical Inpatients. Clin. Nutr. 2023, 42, 1545–1568. [Google Scholar] [CrossRef] [PubMed]
  38. Serón-Arbeloa, C.; Labarta-Monzón, L.; Puzo-Foncillas, J.; Mallor-Bonet, T.; Lafita-López, A.; Bueno-Vidales, N.; Montoro-Huguet, M. Malnutrition Screening and Assessment. Nutrients 2022, 14, 2392. [Google Scholar] [CrossRef] [PubMed]
  39. Arfsten, H.; Cho, A.; Prausmüller, S.; Spinka, G.; Novak, J.; Goliasch, G.; Bartko, P.E.; Raderer, M.; Gisslinger, H.; Kornek, G.; et al. Inflammation-Based Scores as a Common Tool for Prognostic Assessment in Heart Failure or Cancer. Front. Cardiovasc. Med. 2021, 8, 725903. [Google Scholar] [CrossRef]
  40. de van der Schueren, M.A.E.; Keller, H.; Cederholm, T.; Barazzoni, R.; Compher, C.; Correia, M.I.T.D.; Gonzalez, M.C.; Jager-Wittenaar, H.; Pirlich, M.; Steiber, A.; et al. Global Leadership Initiative on Malnutrition (GLIM): Guidance on Validation of the Operational Criteria for the Diagnosis of Protein-Energy Malnutrition in Adults. Clin. Nutr. 2020, 39, 2872–2880. [Google Scholar] [CrossRef]
Figure 1. Flowchart of patient selection in the study.
Figure 1. Flowchart of patient selection in the study.
Nutrients 16 02396 g001
Figure 2. Cumulative hospital mortality risk stratified by malnutrition risk status according to PNI score. (A) Traumatic brain injury, (B) ischemic stroke, (C) hemorrhagic stroke.
Figure 2. Cumulative hospital mortality risk stratified by malnutrition risk status according to PNI score. (A) Traumatic brain injury, (B) ischemic stroke, (C) hemorrhagic stroke.
Nutrients 16 02396 g002
Table 1. Initial parameters, disease characteristics, and outcomes of ICU patients.
Table 1. Initial parameters, disease characteristics, and outcomes of ICU patients.
ParametersTraumatic Brain
Injury (1),
n = 267
Ischemic
Stroke (2),
n = 825
Hemorrhagic Stroke (3),
n = 260
p
1–2–3
p
1–2
p
1–3
p
2–3
Sexmale193, 72%449, 54%148, 57%<0.001 1<0.001 1<0.001 10.51
female74, 28%376, 46%112, 43%
Age, years42 (IQR 29–56)69 (IQR 60–78)59 (IQR 48–68)<0.001 2<0.001 4<0.001 4<0.001 4
BMI, kg/m2* n = 240,
21.8 (IQR 18.9–24.9)
n = 744,
26.1 (IQR 23–30.6)
n = 240,
25.6 (IQR 22.4–29.8)
<0.001 2<0.001 4<0.001 40.4 4
Transfer from other hospital250, 64%803, 97%254, 98%0.016 30.007 30.031 30.9 3
APACHE II at admission, scoren = 15, 6 (IQR 3–10)n = 28, 7.5 (IQR 5–13.5)n = 10, 8 (IQR 6–14)0.4 2---
SOFA at admission, scoren = 182, 3 (IQR 2–4)n = 599, 3 (IQR 1–5)n = 181, 3 (IQR 1–4)0.111 2---
FOUR at admission, scoren = 189, 14 (IQR 11–16)n = 621, 16 (IQR 13–16)n = 191, 15 (IQR 12–16)<0.001 2<0.001 40.1 40.7 4
GCS at admission, scoren = 192, 11 (IQR 9–14)n = 635, 14 (IQR 10–15)n = 195, 14 (IQR 10–15)<0.001 2<0.001 4<0.001 40.9 4
CRS-R at admission, score n = 128, 11 (IQR 6–19)n = 393, 20 (IQR 11–23)n = 121, 18 (IQR 8–22)<0.001 2<0.001 40.017 40.042 4
Pneumonia at admission88, 33%292, 35%89, 34%0.8 1---
Comorbidity
Coronary artery disease17, 6.4%213, 26%44, 17%<0.001 3<0.001 1<0.001 10.003 1
Arterial hypertension82, 31%633, 77%197, 76%<0.001 1<0.001 1<0.001 10.8 1
Type 2 diabetes3, 1.1%52, 6.3%11, 4.2%<0.001 3<0.001 30.031 30.3 3
Anemia17, 6.4%20, 1.4%13, 5.0%0.005 30.005 30.6 30.06 3
Laboratory parameters and malnutrition risk assessment at admission
PNI score33.4 (IQR 28.2–37.7)32.2 (IQR 27.3–36.7)31.3 (IQR 27.9–35.3)0.025 20.1 40.016 40.7 4
StatusNormal60, 23%159, 20%32, 12%0.012 10.4 10.002 10.014 1
Moderate47, 18%135, 16%37, 14%
Severe160, 60%531, 64%191, 74%
WBC, 109/L8.2 (IQR 6.6–11)8.8 (IQR 6.8–11.5)8.6 (IQR 6.5–11.6)0.127 2---
Lymphocyte count, 109/L1.4 (IQR 1.1–1.8)1.2 (IQR 0.9–1.8)1.2 (IQR 0.9–1.8)0.005 20.004 40.1 40.9 4
Neutrophil count, 109/L5.6 (IQR 4.3–8.4)6.4 (IQR 4.5–9.2)6.4 (IQR 4.5–8.9)0.027 20.024 40.1 40.9 4
NLR4.3 (IQR 2.6–6.9)5 (IQR 3.1–9)5 (IQR 2.9–8.7)<0.001 20.001 40.02 40.9 4
Platelets, 109/L337 (IQR 251–429)255 (IQR 201–328)305 (IQR 228.5–379.5)<0.001 2<0.001 40.01 4<0.001 4
INRn = 262, 1.18 (IQR 1.1–1.3)n = 816, 1.15 (IQR 1.1–1.3)n = 258, 1.15 (IQR 1.1–1.3)0.026 20.02 40.4 40.9 4
Albumin, g/L33.4 (IQR 28.2–37.7)32.2 (IQR 27.3–36.7)31.3 (IQR 27.9–35.3)0.025 20.1 40.025 40.7 4
Total protein, g/Ln = 264,
65.1 (IQR 58.5–69.7)
n = 795,
62 (IQR 56.1–67.6)
n = 254,
61.8 (IQR 56.2–66.3)
<0.001 2<0.001 4<0.001 40.9 4
Cholesterol, mmol/Ln = 16, 4.9 (IQR 4.4–6.3)n = 64, 3.9 (IQR 3.1–4.7)n = 23, 4.4 (IQR 3.1–5.6)0.009 20.008 40.3 40.7 4
Outcomes
Hospital mortality18, 6.7%122, 14.8%21, 8.1%<0.001 3<0.001 30.6 30.004 3
Hospital length of stay, days39 (IQR 24–63)31 (IQR 22–47)36 (IQR 24–56)<0.001 2<0.001 40.9 40.001 4
Need for MV126, 47%360, 44%137, 53%0.035 10.3 10.2 10.011 1
Use of vasoactive drugs44, 17%144, 18%34, 13%0.3 1---
Discharge
department
ICU
palliative psych. ward
neurorehabilitation
126, 43%386, 47%130, 50%0.5 1---
69, 26%209, 25%72, 28%
72, 27%230, 28%58, 22%
1—Chi-square test; 2—Kruskal–Wallis test; 3—Fisher’s exact test (Fisher–Freeman–Halton exact test); 4—Mann–Whitney U-test. * Number of patients (n) is given when missing data are present. Bonferroni multiple-significance-test correction applied (statistical significance set at p < 0.017). Abbreviations: ICU, intensive care unit; BMI, body mass index; APACHE II, acute physiology and chronic health evaluation II; SOFA, Sequential Organ Failure Assessment; FOUR, Full Outline of UnResponsiveness; GCS, Glasgow coma scale; CRS-R, Coma Recovery Scale-Revised; MV, mechanical ventilation; PNI, prognostic nutritional index; WBC, white blood cell count; NLR, neutrophil-to-lymphocyte ratio; INR, International Normalized Ratio; IQR, interquartile range.
Table 2. Cox regression analysis (outcome of hospital mortality).
Table 2. Cox regression analysis (outcome of hospital mortality).
ParametersUnivariate Analysis
HR (95% CI)
p ValueMultivariable Analysis
adj. HR (95% CI)
p Value
Sex (ref. male)1.59 (1.16–2.16)0.003 0.8
Age *1.044 (1.032–1.055)<0.0011.038 (1.023–1.052)<0.001
SOFA *1.37 (1.30–1.45)<0.0011.33 (1.26–1.41)<0.001
FOUR0.85 (0.82–0.89)<0.001 0.4
GCS0.85 (0.81–0.90)<0.001 0.2
CRS-R0.94 (0.91–0.97)<0.001
Pneumonia at admission2.17(1.59–2.96)<0.001 0.3
Coronary artery disease2.23 (1.58–3.14)<0.001 0.1
Arterial hypertension1.84 (1.28–2.64)<0.001 0.9
Type 2 diabetes2.08 (1.12–3.86)0.020 0.9
Anemia0.67 (0.21–2.11)0.5 -
Ischemic stroke (ref. TBI)3.06 (1.85–5.04)<0.001 0.4
Hemorrhagic stroke
(ref. TBI)
1.45 (0.77–2.73)0.3 -
PNI score0.918 (0.893–0.943)<0.001 0.8
* Remained in the final model (backward stepwise (Wald) method, step 12). Abbreviations: SOFA, Sequential Organ Failure Assessment; FOUR, Full Outline of UnResponsiveness; GCS, Glasgow coma scale; CRS-R, Coma Recovery Scale-Revised; PNI, prognostic nutritional index; HR, hazard ratio; CI, confidence interval.
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Shestopalov, A.E.; Yakovleva, A.V.; Yadgarov, M.Y.; Sergeev, I.V.; Kuzovlev, A.N. Prevalence and Impact of Malnutrition Risk on Outcomes in Critically Ill Patients with Traumatic Brain Injury and Stroke: A Retrospective Cohort Study Using Electronic Health Records. Nutrients 2024, 16, 2396. https://doi.org/10.3390/nu16152396

AMA Style

Shestopalov AE, Yakovleva AV, Yadgarov MY, Sergeev IV, Kuzovlev AN. Prevalence and Impact of Malnutrition Risk on Outcomes in Critically Ill Patients with Traumatic Brain Injury and Stroke: A Retrospective Cohort Study Using Electronic Health Records. Nutrients. 2024; 16(15):2396. https://doi.org/10.3390/nu16152396

Chicago/Turabian Style

Shestopalov, Alexander E., Alexandra V. Yakovleva, Mikhail Ya. Yadgarov, Ivan V. Sergeev, and Artem N. Kuzovlev. 2024. "Prevalence and Impact of Malnutrition Risk on Outcomes in Critically Ill Patients with Traumatic Brain Injury and Stroke: A Retrospective Cohort Study Using Electronic Health Records" Nutrients 16, no. 15: 2396. https://doi.org/10.3390/nu16152396

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop